Table 2.
Guidelines for studies of clinical populations with resting state fcMRI.
| (1) A priori hypotheses regarding a region or network with abnormal fcMRI and clear criteria for selecting this region or network |
| (2) A priori hypothesis and demonstration of a region or network with normal fcMRI to serve as a control |
| (3) Correlation with clinical variables whenever possible |
| (4) Stringent correction for multiple comparisons |
| (5) An analysis of movement in patients and control subjects |
| (6) An analysis of the differential impact of pre-processing in patients and control subjects |
| (7) A discussion of how current findings relate to prior fcMRI findings |